(1 - 16 von 27
)
BMS and Celgene to research cancer immunotherapy combo - PMLiVE
www.pmlive.com
Markus Renschler, global head of haematology and oncology medical affairs, Celgene, said: “We believe that Abraxane is appropriate as a ...
Pancreatic Cancer Research Team (PCRT) celebrates its 10-year ...td2inc.com › news › pancreatic-cancer-research-tea...
td2inc.com
... patients with pancreatic cancer” said Markus Renschler, MD, Corporate Vice President, Global Head of Hematology & Oncology Medical Affairs at Celgene.
BMS, Celgene collaborate on a combination trialBioSpectrum Asia
biospectrumasia.com
— Mr Markus Renschler, MD, senior vice president, global head of hematology and oncology medical affairs, Celgene said, "Our collaboration ...
UK knows ‘almost nothing’ about pancreatic cancer - PMLiVE
www.pmlive.com
Markus Renschler, senior VP and global head of hematology and oncology medical affairs for Celgene, said: “Putting a dent in the rather grim ...
sortiert nach Relevanz / Datum